SOURCE: Xtalks

Xtalks Webinars

March 29, 2016 07:00 ET

Achieving Effective Haematological Oncology Clinical Trials, New Webinar Hosted by Xtalks

TORONTO, ON --(Marketwired - March 29, 2016) - The worldwide broadcast taking place on Thursday, April 14, 2016 at 10am EDT (3pm BST/UK) will examine the nuances of successfully conducting haematological oncology clinical trials. The featured presenters from Novella Clinical include Chris Smyth, Ph.D., managing director of European and Asian operations, and Richard Gams, M.D., chief scientific officer.

Haematological malignancies such as leukaemia, multiple myeloma and lymphoma represent a subset of indications within oncology that are wholly different from solid tumours. The growing haematological oncology therapy market is fueling both large numbers of clinical studies and, more importantly, an enhanced and refined understanding of cancer pathologies. Conducting clinical trials in haematological malignancies requires an understanding of a rapidly evolving treatment paradigm that is increasingly nuanced, complex and patient-directed. Companies developing haematological oncology therapies must capitalise on the principles and infrastructures shared by solid tumour oncology trials while adapting endpoints, study designs and data management approaches as well as considering patients' experiences to address the particular challenges related to investigating candidate treatments for blood-based cancers.

Join this webinar to gain an understanding of critical differences between solid tumour and haematological oncology and a discussion on the nuances of conducting successful haematological oncology clinical trials.

Learning Objectives

  • Understand critical trial design considerations; including tumour type, standard of care vs research interests, and overall data capture nuances
  • Learn how to create meaningful, measurable endpoints and how they differ from solid tumour studies
  • Recognize how to effectively monitor and manage data and queries within oncology studies
  • Gain insight into selecting ideal trial sites for rare haematological malignancies and the importance of working with an oncology-experienced team

To learn more about this event visit: Achieving Effective Haematological Oncology Clinical Trials

About Xtalks

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2016/3/28/11G089311/Images/V-Novella_Clinical-4C-831863263649.jpg

Contact Information